NIB_0605.indd Blueprint North America, a Toronto, Canada-based nonprofit that builds and operates globally used proteomic databases, on May…
Companies seeking an extension to their EU-wide drug’s patent protection, should base their calculations on the time of market authorization…
European governments see manufacturing as a vital next step toward developing a robust local biotech industry—and an essential fortification…
The long-awaited European Centre for Disease Prevention and Control (ECDC) will in May open its doors in Stockholm. But some experts say the center…
On March 31, the European Commission (EC) proposed to raise fees for the authorization of pharmaceuticals at the European Medicines Agency (EMEA).…
With commercialization of academic research slowly rising, debate is brewing over whether spinning off young companies can become too much of…
Dutch researchers kept outbreak secret so they could publish data, report says. Dutch researchers are being accused of aggravating an outbreak…
Starting April 1, researchers in Sweden will be able to legally clone human cells for therapeutic purposes, like their UK colleagues. On February…
Future revenues of many biotech companies are at significant risk because of new US government powers to lower the costs of drugs administered…
On January 18, German proteomics company Biobase tripled in size overnight by acquiring a database subsidiary of Incyte of Wilmington, Delaware,…